![[dr. bob]](/dr-bob-sm.gif)
Dr. Bob is Robert Hsiung, MD,
bob@dr-bob.orgShown: posts 1 to 3 of 3. This is the beginning of the thread.
Posted by Lamdage22 on October 31, 2016, at 5:04:09
I cant seem to find that much info online. I think it hits the market next year.
Posted by Jonhed on October 31, 2016, at 7:11:26
In reply to Zicronapine (AAP), posted by Lamdage22 on October 31, 2016, at 5:04:09
Zicronapine is discontiunued due to make room for another aap that seems to be very promising by lundbeck that has high affinity over D1 vs D2, which is good news for me who can't tolerate high D2 antagonists due to EPS.
And it doesn't have very high affinity for 5-ht2 from what i know, and that is good news for people who gain much weight from zyprexa!
You can read about it here: http://investor.lundbeck.com/releasedetail.cfm?releaseid=960101
Kind regards/J
Posted by Lamdage22 on October 31, 2016, at 13:01:54
In reply to Re: Zicronapine (AAP), posted by Jonhed on October 31, 2016, at 7:11:26
Thanks for sharing
This is the end of the thread.
Psycho-Babble Medication | Extras | FAQ
Dr. Bob is Robert Hsiung, MD,
bob@dr-bob.org
Script revised: February 4, 2008
URL: http://www.dr-bob.org/cgi-bin/pb/mget.pl
Copyright 2006-17 Robert Hsiung.
Owned and operated by Dr. Bob LLC and not the University of Chicago.